Attorney Jason Itkin Featured in Johnson & Johnson News Update

Proving the power of litigation to change the national landscape, Johnson & Johnson has decided to stop distributing talc-based baby powder in the United States and Canada. The announcement was included in the company’s “portfolio assessment” regarding the coronavirus pandemic, but the talc-based product has been the source of controversy for far longer than COVID-19 has been around. The company is facing approximately 20,000 lawsuits related to its talc-based baby powder and reports that it causes ovarian cancer.

While the company plans on marketing and distributing its cornstarch-based baby powder, ending distribution for the talc-based product is considered a major compromise in light of talcum powder’s links to ovarian cancer and mesothelioma. Still, the talc-based version of the product will continue to be sold outside the U.S. and Canada where, as J&J observe, demand is higher.

Consulting Noted J&J Adversary & Critic, Jason Itkin

News site New Brunswick Today, a paper located near Johnson & Johnson’s headquarters, published a story about J&J’s decision to cease distribution of one of its most famous products. To weigh in on the decision, they spoke to our own Attorney Jason Itkin, who has tried multiple cases against J&J and its child companies.

“In Risperdal, we have proved that Johnson & Johnson knew that their drug hurt children, and they chose to hide that information from doctors, patients, and the FDA,” Mr. Itkin was quoted saying. “It is the same with how J&J knew that its talcum powder contained asbestos and decided not to let anyone know of the danger.”

“These are not isolated incidents,” he went on. “Johnson & Johnson systematically and continuously has concealed the dangers of its products in the name of profit.”

Representing People Who’ve Developed Ovarian Cancer Due to Talc

For decades, talcum powder has been linked to increased risk of ovarian cancer. While the mechanics of how talcum powder causes ovarian cancer are unconfirmed, experts believe that talc fibers can end up in the ovarian tissue, binding to it and causing problems that ultimately result in a cancerous tumor. 

Arnold & Itkin is currently investigating Johnson & Johnson for their role in marketing talc-based products without issuing a warning about the increased risk of ovarian cancer. This is the second major product liability issue we’ve taken up against the global manufacturer, the first being Johnson & Johnson’s failure to warn patients about their drug Risperdal's ability to disfigure growing children. 

If you or a loved one developed ovarian cancer after using talc-based baby powder, speak with our ovarian cancer firm as soon as possible in a free consultation. Let’s figure out your recovery options.